INS and type 1 diabetes mellitus: The high cost of managing T1DM, particularly the cost of insulin, imposes substantial financial stress on both patients and the healthcare system.22 The convergence of these difficulties and high rates of patient drop-out underscores the urgent need for reforms aimed at improving patient retention and streamlining continuous, effective care.